Europe Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, and Others) and End User (Diagnostic Laboratories & Reference Laboratories, Research Institutes, and Others)
Market Introduction
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Get more information on this report :
Market Overview and Dynamics
The Europe histopathology services market is expected to reach US$ 10,327.65 million by 2028 from US$ 7,202.97 million in 2021; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. Factors such as strategic alliances among market players and increasing prevalence of chronic diseases drive the market growth. However, limitations associated with histopathology and immunohistochemistry hinder the Europe histopathology services market growth.
Chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, are the leading causes of death and disabilities worldwide. Rapid change in lifestyle, and surge in the consumption of alcohol and tobacco products are among the prominent factors triggering the incidence of cancer among populations. Autoimmune diseases further contribute to disorders among a significant number of people. However, increasing research activities to develop effective treatments for these diseases are boosting the Europe histopathology services market growth. Researchers and therapists exploring therapies for these diseases conduct detailed histopathological analyses to understand the disease mechanisms, which assist in the designing of therapies for their management. Thus, the rising number of chronic diseases worldwide are fueling the histopathological services market growth. Further, technological developments are allowing medical professionals to upgrade their existing diagnostic procedures and protocols. Innovations in instrumentation, visualization tools, and invasion techniques are bringing improvements and greater accuracy in diseases diagnoses. Further, strategic alliances between leading and emerging market players to support the promising studies for advanced histopathological analyses are likely to serve significant future trends in the market. For instance, Telemedicine Clinic (A Unilabs Company), in partnership with Alliance Medical and Doncaster Clinical Commissioning Group (CCG), started providing reporting services for low-dose CT scans, as a part of the Targeted National Lung Health Check program of the National Health Services (NHS), UK.
Europe is facing the massive impact of an outbreak due to exponential growth of infections of COVID-19 in the region. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Hence, due to the lockdown in many countries, elective and cancer surgeries have reduced significantly. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 tests. The rapid increase in the number of infected patients in the UK and Germany is likely to hamper the growth of Europe histopathology services market and result in slowing down the market growth in the near future.
Key Market Segments
The Europe histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. In 2021, the surgical specimen segment is likely to hold the largest share of the market, and it is further expected to register the highest CAGR during 2021–2028.
Based on end user, the Europe histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. The diagnostic laboratories and reference laboratories segment is likely to hold the largest share of the market in 2021, and it is anticipated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe histopathology services market are the European Union (EU), European Society for Medical Oncology (ESMO), and Cancer Research UK.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe histopathology services market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe histopathology services market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe histopathology services market.
EUROPE HISTOPATHOLOGY SERVICES MARKET SEGMENTATION
By Type of Examination
- Surgical Specimen
- Breast Biopsy
- Lung Biopsy
- Renal Biopsy
- Gastrointestinal Biopsy
- Pancreatic Biopsy
- Skin Tissue Biopsy
- Testicular Biopsy
- Others
By End User
- Diagnostic Laboratories & Reference Laboratories
- Research Institutes
- Others
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Acculabs Diagnostics UK Ltd
- Laboratory Corporation of America Holdings
- TPL Path Labs
- UNILABS
- Cellular Pathology Services
- Targos
- Cureline Global Translational CRO
- CHARLES RIVER LABORATORIES, INC.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Histopathology Services Market – By Type of Examination
1.3.2 Europe Histopathology Services Market – By End User
1.3.3 Europe Histopathology Services Market – By Country
2. Histopathology Services Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Histopathology Services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Expert Opinions
5. Histopathology Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Biologics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Histopathology and Immunohistochemistry
5.3 Future Trends
5.3.1 Strategic Alliances Among Market Players
5.4 Impact Analysis
6. Histopathology Services Market – Europe Analysis
6.1 Europe Histopathology Services Market Revenue Forecast and Analysis
7. Histopathology Services Market Analysis – By Type of Examination
7.1 Overview
7.2 Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
7.3 Surgical Specimen
7.3.1 Overview
7.3.2 Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Breast Biopsy
7.4.1 Overview
7.4.2 Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Lung Biopsy
7.5.1 Overview
7.5.2 Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Renal Biopsy
7.6.1 Overview
7.6.2 Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Gastrointestinal Biopsy
7.7.1 Overview
7.7.2 Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pancreatic Biopsy
7.8.1 Overview
7.8.2 Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Skin Tissue Biopsy
7.9.1 Overview
7.9.2 Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Testicular Biopsy
7.10.1 Overview
7.10.2 Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8. Histopathology Services Market Analysis – By End User
8.1 Overview
8.2 Histopathology Services Market Share, by End User, 2021 and 2028, (%)
8.3 Diagnostic Laboratories and Reference Laboratories
8.3.1 Overview
8.3.2 Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Research Institutes
8.4.1 Overview
8.4.2 Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
9. Histopathology Services Market – Europe Analysis
9.1 Europe: Histopathology Services Market
9.1.1 Overview
9.1.2 Europe: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.1.3 Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2 Germany: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.3.3 Germany: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.4 UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.1 UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.2 UK: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.4.3 UK: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.5 France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1 France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2 France: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.5.3 France: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.6 Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 Spain: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.6.3 Spain: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.7 Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Italy: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.7.3 Italy: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.8 Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Rest of Europe: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.8.3 Rest of Europe: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Histopathology Services Market
10.1 Europe: Impact Assessment Of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Developments by Key Market Players
11.2.1 Overview
12. Company Profiles
12.1 Laboratory Corporation of America Holdings
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Acculabs Diagnostics UK Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 TPL Path Labs
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 UNILABS
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cureline Global Translational CRO
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Targos
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Cellular Pathology Services
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 SWOT Analysis
12.7.5 Key Developments
12.8 CHARLES RIVER LABORATORIES, INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
Table 2. Germany Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 4. UK Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 5. UK Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 6. Incidence, Mortality and Prevalence By Cancer Site, 2018, France
Table 7. France Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 8. France Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 9. Spain Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 10. Spain Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 11. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 12. Italy Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Europe Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Europe Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 16. Developments Done by Key Players
Table 17. Glossary of Terms, Histopathology Services Market
LIST OF FIGURES
Figure 1. Histopathology Services Market Segmentation
Figure 2. Histopathology Services Market Segmentation, By Country
Figure 3. Histopathology Services Market Overview
Figure 4. Surgical Specimen Segment Held Largest Share of Histopathology Services Market
Figure 5. Europe Histopathology Services Market – Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. Histopathology Services Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Histopathology Services Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
Figure 10. Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Histopathology Services Market Share, by End User, 2021 and 2028 (%)
Figure 20. Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe: Histopathology Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Europe: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in European Country Markets
- Acculabs Diagnostics UK Ltd
- Laboratory Corporation of America Holdings
- TPL Path Labs
- UNILABS
- Cellular Pathology Services
- Targos
- Cureline Global Translational CRO
- CHARLES RIVER LABORATORIES, INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe histopathology services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe histopathology services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.